AlveoliX Company

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Investors

Industry: PharmTech
Headquarters: Bern
Visit Website
Register and Claim Ownership